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Recent studies of the mechanisms involved in the production of experi- 
mental renal hypertension show that humoral pressor agents are involved. 
It appears that either one or both of two types of pressor substance may 
be liberated from the kidney itself, but that a single type of substance 
acts to produce the peripheral vasoconstriction. One type of substance 
that may be liberated from the kidney has the properties of a non-dialyzable 
protein, like the renin of Tigerstedt and Bergmann (1). This substance 
reacts with certain serum constituents to produce a dialyzable amine type 
of pressor substance, according to Page, Koehlstaedt, and Helmer (2, 3), 
who called this substance angiotonin, and according to Braun-Menendez 
and coworkers (4), who called it hypertensin. Another type of substance 
that may be liberated from the kidney has the properties of a dialyzable 
pressor amine that is very possibly tyramine or hydroxytyramine, as de- 
veloped by the work of Holtz (5, 6) and of Bing (7, 8) and their coworkers. 
Whatever the substances liberated by the kidney may be, it appears that 
the humoral agent producing a peripheral vasoconstriction is an amine in 
type, and very possibly a phenolic amine. 
The pressor effect of renin can be inactivated by tyrosinase preparations 
in the presence of oxygen, and the product of its interaction with serum, 
angiotonin or hypertensin, can be similarly inactivated, as shown by 
Schroeder and Adams (9) and confirmed by Croxatto and Croxatto (10). 
The latter workers also showed that hypertensin could be readily inac- 
tivated by amine oxidase preparations in the presence of oxygen. Schroe- 
der and Adams studied the effects of injected tyrosinase preparations on 
the blood pressures of animals with experimental renal hypertension, and 
also of persons having arterial hypertension (11). Falls in blood pressure 
and other signs of clinical improvement were obtained, and the conclusion 
was drawn that it was probable that some phenolic substance acting as a 
humoral agent was altered. A recent note by Schroeder (12) reports that 
the injection of amine oxidase preparations lowered the blood pressure of 
animals with experimental renal hypertension. 
The tissues of mammals, as studied by Bhagvat and Richter (13), do 
not normally contain any considerable amounts of tyrosinase or other 
phenoloxidases. The physiological inactivation of phenolic amines in 
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man appears to be largely carried out by some esterifying mechanism, as 
shown by Richter and Richter and Macintosh (14, 15). It is therefore of 
considerable interest to value the kinetics of phenoloxidase-catalyzed 
oxidations of a number of phenolic pressor amines, under approximate 
physiological conditions, in order to estimate the r&e any normally occur- 
ring amounts could play in the inactivation of such compounds in the body. 
Such data also furnish bases for consideration of the possible effects of 
injected amounts of tyrosinase or other phenoloxidase preparations. 
Basic to the consideration of the action of tyrosinase on the oxidation of 
phenolic pressor amines are the observations of Keilin and Mann (16) and 
of Nelson and his coworkers (17-19) that show that different preparations 
may vary considerably in their relative actions on monophenols and 
o-diphenols. Both of these types of activity appear to belong to the same 
enzyme complex, as they bear a proportionality to the same copper con- 
tent. However, since the activities vary with the purity and method of 
purification, each enzyme preparation must be defined in terms of both 
monophenolase and o-diphenolase activities. This was done in the present 
studies, and modifications of previously described preparative methods 
were required to retain a reasonable proportioning of such activities in 
purified preparations. 
Purijied Tyrosinase Preparations 
The methods described by Nelson and coworkers (17-19) were first tried, 
but met with little success, owing to rapid inactivation and processing 
losses. The methods of Keilin and Mann (16) were then tried, and after 
some modification it was possible to obtain quite good yields of stable 
preparations which were 30 to 40 times more active per unit weight than 
crude aqueous extracts. In our experience, only a white cultivated variety 
of the common mushroom gave good results, a spotted brown and white 
variety gave fair results, while a brown variety gave precipitates that were 
difficult to handle and high inactivation and processing losses occurred. 
The tyrosinase activity of the preparations was valued by methods 
similar to those of Adams and Nelson (17), but modified by use of available 
equipment. The assays were made with an Aminco Warburg apparatus, 
with seven 15 ml. vessels shaken at 120 oscillations per minute in a 30.0” 
water bath. In the body of the flasks were placed 1.0 ml. of 0.4 M sodium 
phosphate buffer, pH 7.0, containing 2.5 mg. of gelatin, and 0.5 ml. of 
enzyme preparation at a dilution to cause an oxygen uptake of about 5 
microliters per minute. In the side arm was placed either 0.5 ml. of a 
solution containing 0.1 mg. of catechol and 5 mg. of hydroquinone per ml. 
for catecholase activity determination or 0.5 ml. of 0.04 M p-cresol for 
cresolase activity determination. The solutions were attemperated for 
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15 minutes with shaking at a 2 cm. stroke, and then mixed and shaking 
continued at a 4 cm. stroke. For catecholase activity, readings were made 
at 2 minutes, while for cresolase activity, readings were made at 5 minute 
intervals. In either case, a unit (catecholase = Ca. u., cresolase = Cr. 
u.) is defined as that which causes an uptake of 10 microliters of 02 per 
minute under the conditions used. The unit was found to be seven- 
twelfths that of the unit similarly defined by Adams and Nelson for their 
equipment. 
Crude Extract-5 pounds of fresh mushrooms were ground twice, mixed 
with 200 ml. of water, and then pressed in a canvas bag. Regrinding with 
sand and 400 ml. of water, repressing, then another grinding with sand and 
600 ml. of water gave about 2700 ml. of reddish brown liquid. 
Non-dialyzable solids, 6.52 mg. per ml., 5 Ca. u. per mg., 7 Cr. u. per mg. Total 
Ca. u., 92,000; total Cr. u., 123,000. 
Ammonium Sulfate Precipitation, Followed by Dialysis-Crude extract 
adjusted with N acetic acid to pH 5 was treated with 700 gm. per liter of 
ammonium sulfate and the pH adjusted to 4.8, with stirring for 2 hours. 
Centrifugation in a Sharples machine at 25,000 R.P.M. completed the solid 
separation in an hour, while filtration attempts were discouraging. The 
solid was resuspended in 450 ml. of water with stirring for 0.5 hour, and the 
mixture then dialyzed within 36132 Visking cellophane tubing by shaking 
in running tap water for 24 to 40 hours. Insoluble material was centri- 
fuged out and the centrifugate made up to 1000 ml. 
Non-dialyaable solids, 4.09 mg. per ml., 34 Ca. u. per mg., 29 Cr. u. per mg. Total 
Ca. u., 139,OOO;r total Cr. u., 118,000. 
Lead Acetate Treatment-Aliquots of 20 ml. were taken and treated with 
0.6 to. 1.4 ml. of 0.05 saturated lead acetate solution to determine the ap- 
proximate amount required to effect removal of color to a green filter read- 
ing of about 300 on a Klett calorimeter. The total batch had to be treated 
with a 20 to 25 per cent greater ratio of the lead acetate solution to obtain 
equivalent decolorization, and was then centrifuged. 
Non-dialyzable solids, 1.47 mg. per ml., 57 Ca. u. per mg., 41 Cr. u. per mg. Total 
Ca. u., 83,000; total Cr. u., 59,000. 
Clari;fication with Calcium Phosphate-Treatment of the extract with some 
freshly precipitated calcium phosphate at pH 7.0, by stirring for 0.5 hour 
1 Assay shows an increase in total Ca. u. during ammonium sulfate precipitation 
followed by dialysis, and this was shown by several, but not all, the preparations 
made. Keilin and Mann (16) also observed such an increase and postulated the pres- 
encc of a proenzymc that was activated during dialysis. 
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and then allowing it to stand overnight, gave a clear solution after centrif- 
ugation, about two-thirds as colored as after the lead acetate treatment. 
Non-dialyzable solids, 1.07 mg. per ml., 76 Ca. u. per mg., 55 Cr. u. per mg. Total 
Ca. u., 80,000; total Cr. u., 58,000. 
The calcium phosphate was prepared by mixing equal volumes of 0.15 M 
calcium acetate and 0.1 M disodium phosphate and adjusting the pH to 
that at which the suspension was to be used. .l ml. of this is equivalent to 
15 mg. of tricalcium phosphate. 
Calcium Phosphate Adsorption and Elution-80 per cent of the activity 
was adsorbed by adjustment of the pH to 6.6 and treatment with 1 gm. of 
calcium triphosphate in suspension at pH 6.6 for each 20,000 Ca. u. by 
stirring for 0.5 hour. The adsorption precipitate was centrifuged off with 
the Sharples machine, and then stirred for an hour into a suspension with 
75 ml. of 0.5 M potassium phosphate buffer at pH 7.5. The eluate was 
centrifuged off and elution repeated twice. The combined eluates were 
dialyzed against running tap water for 40 hours. 
Non-dialyzable solids, 1.41 mg. per ml., 140 Ca. u. per mg., 90 Cr. u. per mg. Total 
Ca. u., 51,000; total Cr. u., 32,000. 
By treatment of such solutions with small amounts of 0.01 saturated lead 
acetate and with calcium phosphate suspensions, about half of the enzymic 
activity could be obtained in preparations showing about 210 Ca. u. per 
mg. with 110 Cr. u. per mg. 
For use in experimental renal hypertension in animals, or in arterial 
hypertension in man, more concentrated solutions of the calcium phosphate 
eluate preparations were desired. These were prepared by precipitating 
relatively large volumes of eluate preparations with 700 gm. per liter of 
ammonium sulfate and adjusting the pH to 4.8. The precipitate was 
taken up with 0.9 per cent sodium chloride solution at pH 7.0, and made 
1: 50,000 in phenylmercuric acetate for preservation. Such solutions 
contained non-dialyzable solids, 3.72 mg. per ml., 300 Ca. u. per mg., 90 
Cr. u. per mg. The stability of the more highly purified preparations, 
when kept in the refrigerator at about 5”, was very satisfactory. One 
preparation that was tested almost weekly for 5 months showed no change 
in either catecholase or cresolase activity. Another preparation carefully 
restandardized after 3 months showed no change in either type of activity. 
These tyrosinase preparations could be rapidly inactivated by heating 
above 60”, with the attendant precipitation of coagulated proteins. Study 
of this heat inactivation showed that by keeping the preparations at 60” 
for 40 minutes, 95 per cent or more of the catecholase and cresolase activity 
was destroyed. Such heating did cause precipitation of some material 
which almost completely dissolved on cooling and shaking. 
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Tyrosinase Oxidations of Phenolic Amines 
The relative activity of tyrosinase preparations when tested upon mono- 
phenols and o-diphenols may not be reflected in their relative activity when 
tested upon monophenolic and o-diphenolic amines. This question was 
especially studied, since it appeared possible that, although preparations 
might vary considerably in their relative catecholase to cresolase activity, 
certain generalizations might be made for the action of tyrosinase on types 
~4i,YDROXYPHfNfTrrti AMNf 
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Ik. 1. Oxygen uptake in microliters against time in minutes for preparations 
having different ratios of catccholase to cresolase activity. A and B may bc con- 
sidered high catecholase, C and D high cresolase preparations. The cxperimcnts 
were carried out at 30” with 0.01 M amine hydrochloride substrates in 0.2 M sodium 
phosphate buffer, pH 7.0, and 0.5 ml. of enzyme of the concentration shown per ml. 
used in a 2 ml. total volume. The curve numbers in all four sections correspond to 
the substrates listed in A. 
of phenolic amines, and particularly on phenolic pressor amines that might 
occur in the body under physiological conditions. Confirmation of this 
idea was indeed obtained by the study of four enzyme preparations, vary- 
ing widely in their relative catecholase to cresolase activity upon the same 
series of six amincs. Three of these amincs were monophenolic; t,hc other 
three were diphenolic and derivatives of catechol. 
Three enzyme preparations were made by following the previously out- 
lined methods, and represented a range from a relatively high catecholase 
to cresolase ratio of 10: 1 through a ratio of 10: 2.5, and finally of 10: 6. 
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The oxidation rates were studied for these three preparations at 30”, with 
0.5 ml. of enzyme preparation containing 1.0 Ca. u. per ml. and attendant 
cresolase unitage, and 0.5 ml. of 0.04 M phenolic amine, in a total volume 
of 2.0 ml. Curves showing the results are given as A, B, and C of Fig. 1. 
A high cresolase preparation was also made specially for this comparative 
study by fractional ammonium sulfate precipitation of a crude extract of 
brown mushrooms. This preparation showed a catecholase to cresolase 
ratio of 10:33, and 0.5 ml. of enzyme preparation containing 1.0 Cr. u. 
per ml. and but 0.3 Ca. u. per ml. was used for the studies shown in Fig. 
1, D. 
FIG. 2. Oxygen uptake in microliters against time in minutes, at 30” with 0.01 M 
amine hydrochloride substrates in 0.2 M sodium phosphate buffer, pH 7.0, and 0.5 
ml. of enzyme used in a 2 ml. total volume. In A the enzyme solution used contained 
1.0 Ca. u. and 0.6 Cr. u. per ml., and in B the enzyme concentration was 24 times 
greater. Curve 1, 3.hydroxyphenethylaminc; Curve 2, 4-hydroxyphenethylamine; 
Curve 3, 4.hydroxyphenethylmethylamine; Curve 4, 4-hydroxyphenisopropylamine; 
Curve 5, 3-hydroxyphenethanolmethylamine; Curve 6, 4-hydroxyphenethanolme- 
thylamine; Curve 7, 3,4-dihydroxyphenethylamine; Curve 8, 3,4-dihydroxyphene- 
thylmethylamine; Curve 9, 3,4-dihydroxyphenisopropylamine; Curve 10, 3,4-dihy- 
droxyphenethanolamine; Curve 11, dl-3,4-dihydroxyphenethanolmethylamine; 
Curve 12, I-3,4-dihydroxyphenethanolmethylamine. 
The results from monophenolic and diphenolic amine substrates fall 
into separate groups with each of the several enzyme preparations. The 
principal point of difference in the action of the four preparations is the 
greater spread of the curves with increased cresolase activity. The 
cresolase activity appears to potentiate the catecholase activity of the 
preparations of high cresolase activity with respect to all six of the sub- 
strates studied. 
To further the idea that oxidation behavior of phenolic pressor amines 
may be classified on the basis of the number and position of the benzene 
ring substituents, additional studies were carried out on a rather varied 
series of phenolic and o-diphenolic amines. For the initial study, a single 
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tyrosinase preparation with a catecholase to cresolase ratio of 10: 6 was 
used, with enzyme and substrate concentrations as in the studies of A, B, 
and C of Fig. 1. A second study was carried out with enzyme concentra- 
tions 24 times as great and with longer periods of observation, to indicate 
the total extent of oxidation of these compounds by tyrosinase. The re- 
sults of these studies are shown in Fig. 2, and it should be noted that here 
again the initial rates of the effects upon monophenolic and diphenolic 
amines are separable into groups, with the exception that the S-hydroxy- 
phenylalkyl- (or alkanol-) amines are not oxidized at all. Another point 
of interest is that the ethanolamine side chain appears to inhibit oxidation 
in both series, though not notably with adrenalin. 
The total extent of tyrosinase oxidation of these various substrates, as 
shown by Fig. 2, B, indicates that the course of the oxidation, aside from 
phenolic oxidation, may differ greatly among the various compounds. 
This is perhaps related to the findings of Beyer (20), using certain phenolic 
pressor amines and crude potato tyrosinase preparations, that total oxida- 
tion may involve the splitting of ammonia from the molecule, as well as the 
production of indole derivatives and melanins, as found by Duliere and 
Raper (21). 
Dissociation Constants of Tyrosinase and Phenolic Pressor Amines 
The kinetic dissociation constants of tyrosinase with some typical 
phenolic pressor amine substrates were determined. These substrates 
were chosen because of their physiological or pharmacological interest. 
Although calculations were planned to be made that would apply to body 
temperatures, the studies were carried out in the Warburg apparatus at 
25”. This was done in order to obtain sufficient experimental precision, 
since the rates determined must be those during the first few minutes of 
oxidation, and differences between bath and room temperatures of as much 
as 5” caused manometer shifts affecting the reading for the 1st minute 
owing to the removal of the vessels from the bath for mixing. Substrate 
concentrations varied from 0.002 to 0.02 molal. Enzyme concentrations 
were 3 Ca. u. per ml. with 1.8 Cr. u. per ml. for the monophenolic sub- 
strates, and 0.6 Ca. u. per ml. with 0.36 Cr. u. per ml. for the diphenolic 
substrates. Determinations were repeated in most cases at one-half these 
enzyme concentrations, and checks were obtained. For the monophenolic 
amines, the rates used were the maximum rates obtained over a 5 minute 
period after the initial lag period had ceased, and usually occurred between 
8 and 13 minutes, often continuing constant for an additional 5 minutes. 
For the diphenolic amines, the oxidation rates of which rapidly decrease 
with time, the rates chosen were the maximum rates observed over a 1 
minute interval, usually falling within the 1st or 2nd minute interval. 
By plotting l/V, where V = microliters of 02 uptake per minute, against 
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l/S, where S = molal substrate concentration, the ordinate intercept 
l/V,,,;,,. and the slope of the straight line ZL/VIrLax. were determined, as 
suggested by Lineweaver and Burk (22). K, , the dissociation constant of 
the int,ermediate enzyme-substrate compound, is then easily calculable. 
DISCUSSION 
The data presented with regard to the interaction of oxygen and the 
phenolic pressor amines in the presence of tyrosinase permit some cal- 
culations to be made with respect to the likelihood that tyrosinase plays 
any physiological role in the inactivation of these compounds in the body. 
Further, such calculations can indicate the order of magnitude of the 
amounts of tyrosinase that would have to be introduced into the body from 
the outside to exert an effect comparable to normal rates of destruction of 
these phenolic pressor amines. 
By way of example, consider the oxidation rate of tyramine in a con- 
centration of 1O-5 molal with an enzyme concentration of 3.0 Ca. u. and 
1.8 Cr. u. per ml. by substitution of the data given in Table I for these con- 
ditions into the rate relation l/V = K,/V,,,. (S) + l/V,,,. Such sub- 
stitution gives l/V to be about 24, or V to be about 0.04 microliter of 0, 
per minute, or about 0.02 X 10ei mole of 02 per minute. On the basis 
that physiological inactivation would occur with an uptake of 1 mole of 
O2 per mole, 1OP mole of tyramine under these conditions would require 
about 500 minutes to be inactivated with an enzyme concentration of 
3.0 Ca. u. and 1.8 Cr. u. per ml. Such conditions of amounts and con- 
centrations of tyramine would be approximated in the blood stream of an 
experimental animal immediately following the intravenous injection of 
1OP mole per kilo (0.18 mg. per kilo of hydrochloride) of tyramine. The 
studies of Clark and Raventos (23) on the relationship between dosage and 
duration of physiological actions of tyramine in cats and in man showed 
that a dosage of 1OP mole of tyramine per kilo is inactivated in less than 
20 minutes. 
A similar calculation made from the data obtained on Z-adrenalin in a 
concentration of lo-’ molal with an enzyme concentration of 0.6 Ca. u. 
and 0.36 Cr. u. per ml. would give V to be about 2 X 10e4 microliter of 
O2 per minute, or about lo-l1 mole of 02 per minute. On the basis that 
physiological inactivation would occur with an uptake of 0.5 mole of O2 
per mole, 1OW mole of adrenalin under these conditions would require about 
500 minutes to be inactivated with the enzyme concentration of 0.6 Ca. 
u. and 0.36 Cr. u. per m’. Such conditions of amounts and concentrations 
of adrenalin would be approximated in the blood stream following the 
intravenous injection of 1OP mole per kilo (0.0018 mg. per kilo) of adren- 
alin. The duration of pressor and other responses in cats from such a dos- 
age is less than 5 minutes, and is most commonly 2 to 3 minutes. 
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Certainly, no such considerable amounts of tyrosinase as 3.0 or even 
0.6 Ca. n. per ml. eGt ~~~rma,Ly in t’ne Hood or tissues of animals yet 
studied, as demonstrated by Bhagvat and Richter (13). If a tyrosinase- 
catalyzed oxidation were the principal oxidative mechanism, 25 to 100 or 
more times these concentrations of enzyme would be required. Although 
tyrosinase is thus indicated as being an unimportant mechanism normally, 
it might be suggested that its injection could be resorted to in order to in- 
crease the capacity of the body to inactivate phenolic pressor amines. So 
far as such compounds are represented by tyramine and adrenalin, amounts 
of tyrosinase approximating 25 to 100 or more times 3.0 or even 0.6 Ca. u. 
per ml. of body fluid would be required to be injected to approach de- 
TABLE I 
Tyrosinase Oxidations of Phenolic Amines 
The experiments were carried out at 25’ in 0.2 M sodium phosphate buffer, pH 7.0, 
with substrate concentrations of from 0.002 to 0.02 molal. 
Phenolic amine 
4.Hydroxyphenethylamine (tyramine: 
4-Hydroxyphenisopropylamine 
(paredrine) 
3,4-Dihydroxyphenethylamine (hy- 
droxytyramine) 
3,4-Dihydroxyphenisopropylaminc 
(hydroxyparedrine) 
dl-3,4-Dihydroxyphenethanolmeth- 
ylamine (dl-adrenalin) 
L3,4-Dihydroxyphenethanolmeth- 
ylamine (l-adrenalin) 
Enzyme concen 1 
tration Vmax. 
Cu. 21. 
per ml. 
3.0 
1.5 
3.0 
1.5 
0.6 
0.3 
0.6 
0.3 
0.6 
0.3 
0.6 
Cr. 11. 
per ml. 
1.8 
0.9 
1.8 
0.9 
0.36 
0.18 
0.36 
0.18 
0.36 
0.18 
0.36 
0.104 2.42 0.0024 
0.206 4.03 0.0020 
0.051 3.44 0.0067 
0.100 6.00 0.0060 
0.040 2.00 0.0050 
0.076 4.02 0.0053 
0.047 1.54 0.0033 
0.085 2.90 0.0034 
0.045 3.24 0.0072 
0.090 6.80 0.0075 
0.035 4.60 0.0131 
KS 
vmx. 
x 10-4 
KS 
struction rates comparable to those normally possessed by the body. These 
amounts are very large and are in excess of those that were used by 
Schroeder and Adams (9, 11) for the therapy of hypertension in animals 
and man, and it would seem probable that explanations other than in- 
creased destruction of phenolic pressor amines are required for the effects 
they reported. 
SUMMARY 
1. Methods were developed for the purification of extracts of common 
white mushrooms, giving good yields of stable tyrosinase preparations. 
2. The ratio of catecholase to cresolase activities of such preparations 
was not greatly altered in the course of such purification. 
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3. The initial oxidation rates of diphenolic amines that were derivatives 
of catechol were greater than those of monophenolic amines with tyrosinase 
preparations, whether they are high or low in relative catecholase to 
cresolase activity. 
4. Tyrosinase preparations oxidize a large number of monophenolic and 
o-diphenolic pressor amines, with the exception of those substituted with a 
single hydroxyl group in the 3 position relative to the side chain. 
5. The extent of total oxidation of a number of phenolic pressor amines 
is quite variable, probably due to different pathways of the oxidation of the 
side chain with its amino group. 
6. The kinetic enzyme dissociation constants of tyrosinase-amine com- 
binations were found to be of the same order for the monophenolic and 
diphenolic amine types studied. 
7. The dissociation constants and the oxidation rates of tyrosinase- 
amine combinations are such that this oxidation mechanism cannot account 
for any considerable part of the inactivation of tyramine or epinephrine in 
normal animals, and such oxidation is not more probable for related phe- 
nolic pressor amines. 
8. Injections of large amounts of highly active tyrosinase preparations 
into animals would be required to produce rates of oxidation comparable to 
normal inactivation rates. 
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